Sponsored By

Video: Closure of Kabco Shows FDA's PowerVideo: Closure of Kabco Shows FDA's Power

May 15, 2013

FDA ordered contract manufacturer Kabco Pharmaceuticals to halt production of dietary supplements until it proves its facilities are compliant with GMPs (good manufacturing practices). This follows a warning letter FDA sent the company in 2010 regarding its GMP violations. Anthony Young an attorney at Kleinfeld, Kaplan and Becker, reviewed the consent degree provides some perspective from the SupplySide MarketPlace show floor.

Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.

You May Also Like